The Primary Bone Cancer Consortium Funding Support from the Bone Cancer Research Trust provides funding for UK and international consortium working on bone sarcoma clinical and translational research. The consortium must include researchers from at least 5 countries and at least one group must be based in the UK. Applicants may apply for up to 240,000 GBP for projects spanning at least 3 years. Applications close on July 1, 2022.View this resource Bookmark this resource
The Society’s Board of Directors is pleased to announce the approval of $725,000 in new funding to be awarded as part of the Society’s competitive research grants program for 2022. These funds are made available through the great generosity of friends of the Society and especially through the efforts of our membership families. This year, the funds are dedicated to be used to further the research needs of syndromes as described below.View this resource Bookmark this resource
The Foundation for Prader-Willi Research (FPWR) is dedicated to supporting research to advance the understanding and treatment of Prader-Willi syndrome (PWS). We invite applications for funding on an annual or semiannual basis, in response to a Request for Applications.
FPWR accepts applications in all areas of research relevant to PWS, but we are particularly interested in supporting projects that will lead to new interventions to alleviate the symptoms associated with PWS. FPWR accepts applications from academic, government, non-profit or for-profit research entities. Academic research applicants should have a primary faculty appointment at the level of Instructor or higher. This grant program will be useful for junior faculty in the early stages of their careers, established investigators in other areas of research who wish to enter the field of PWS research, or investigators in the PWS field who are seeking funding to support pilot studies in a new area of PWS research. FPWR seeks to support innovative, high-risk/high reward research in its early stagesView this resource Bookmark this resource
The intent of this request for applications is to solicit and fund projects that will improve our understanding of the biological basis for the development and progression of cystic fibrosis-related diabetes as well as to identify potential novel therapeutic strategies to manage and treat the disease.View this resource Bookmark this resource
IRSF believes that research into a variety of Rett and Rett-related topics is necessary to create treatments and eventual cures for every individual living with Rett syndrome. We proudly invest in such research at every stage: from basic science that can change the way we think about MeCP2 to clinical research that directly impacts potential treatments. We also help connect Rett researchers with external funding opportunities.View this resource Bookmark this resource
For this funding opportunity The ALS Association will accept applications from all scientific disciplines on topics that have the potential to ultimately transform the experience of ALS, by optimizing the care and treatments we have, finding new treatments and cures, and or preventing ALS. In addition to projects focused on ALS, projects that investigate the continuum of disease spanning ALS and FTD are in scopeView this resource Bookmark this resource
ESID wants to invest in the future of researchers and clinicians committed to PIDs. Therefore ESID Bridge Grants aim to allow trainees working on PIDs to continue their activity in the field of PID in their institution or another institution during short periods of time until they can find other financial sources, thus avoiding the interruption of their training process.View this resource Bookmark this resource
The ASF Scientific Advisory Committee identified the following areas of unmet need in AS research. Priority will be given to the following topics:
Projects studying or correcting the heterozygous effect of non-UBE3A genes in deletion.
Projects studying the potential results of increasing UBE3A after therapies or for some subtypes of AS.
Projects studying delivery of therapies and potential for improvement.
Symptomatic therapies that impact the daily life of people with Angelman syndrome and their families.
Proposals that do not address these topics are still welcome and will be given full consideration.
The Progeria Research Foundation (PRF) is a driving force worldwide in finding treatments and the cure for Progeria and its aging-related disorders, including heart disease. We invite qualified scientists with faculty appointments or the equivalent to submit applications for the upcoming grant cycle.View this resource Bookmark this resource